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One Sentence Summary: Comprehensive heritability analysis of brain phenotypes demonstrates a 797	
clear role for common genetic variation across neurological and psychiatric disorders and 798	
behavioral-cognitive traits, with substantial overlaps in genetic risk. 799	
Abstract: Disorders of the brain can exhibit considerable epidemiological comorbidity and share 800	
symptoms, provoking debate about their etiologic overlap. We quantified the genetic sharing of 25 brain 801	
disorders from genome-wide association studies of 215,683 patients and 657,164 controls, and their 802	
relationship to 17 phenotypes from 1,191,588 individuals. Psychiatric disorders share common variant 803	
risk, while neurological disorders appear more distinct from one another and from the psychiatric 804	
disorders. We also identify significant sharing between disorders and a number of brain phenotypes, 805	
including cognitive measures. Simulations were used to explore how power, diagnostic misclassification 806	
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and phenotypic heterogeneity affect genetic correlations. These results highlight the importance of 807	
common genetic variation as a risk factor for brain disorders and the value of heritability-based methods 808	
in understanding their etiology. 809	
Main Text:  810	
The classification of brain disorders has evolved over the past century, reflecting the 811	
medical and scientific communities’ assessments of the presumed root causes of clinical 812	
phenomena such as behavioral change, loss of motor function, spontaneous movements or 813	
alterations of consciousness. Directly observable phenomena (such as the presence of emboli, 814	
protein tangles, or unusual electrical activity patterns) generally define and separate neurological 815	
disorders from psychiatric disorders(1). Understanding the genetic underpinnings and categorical 816	
distinctions between brain disorders may be helpful in informing the search for the biological 817	
pathways underlying their pathophysiology(2, 3). 818	
In general, brain disorders (excepting those caused by trauma, infection, or cancer) show 819	
substantial heritability from twin and family studies(4). Epidemiological and twin studies have 820	
explored patterns of phenotypic overlaps(5-7), and comorbidity has been reported for many pairs 821	
of disorders, including bipolar disorder-migraine(8), stroke-major depressive disorder(MDD)(9), 822	
epilepsy-autism spectrum disorders (ASD), and epilepsy-attention deficit hyperactivity disorder 823	
(ADHD)(10, 11). Furthermore, there may also be direct etiological links, as e.g. mutations in the 824	
same ion channel genes confer pleiotropic risk for multiple distinct brain phenotypes(12-14). 825	
Genome-wide association studies (GWAS) have demonstrated that individual common risk 826	
variants can overlap across traditional diagnostic boundaries(15, 16), and that disorders like 827	
schizophrenia, MDD, and bipolar disorder can have genetic correlations(17).  828	
GWAS have also demonstrated that common genetic variation contributes to the 829	
heritability of brain disorders. Generally, this occurs via the combination of many common 830	
variants, each with a small individual effect, with examples in Alzheimer’s disease(18), bipolar 831	
disorder(19), migraine(20), Parkinson’s disease(21), and schizophrenia(22). In addition to locus 832	
discovery, the degree of distinctiveness(23) across neurological and psychiatric phenotypes can 833	
be evaluated with the introduction of novel heritability-based methods(24) and sufficiently large 834	
sample sizes for robust heritability analysis. These analyses can shed light on the nature of these 835	
diagnostic boundaries and explore the extent of shared common variant genetic influences.  836	
 837	
Study design 838	
The Brainstorm consortium is a collaboration among GWAS meta-analysis consortia of 839	
25 disorders (see Table 1), to perform a comprehensive heritability and correlation analysis of 840	
brain disorders. We included meta-analyses of any common brain disorders for which we could 841	
identify a GWAS meta-analysis consortium of sufficient size for heritability analysis. The total 842	
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study sample consists of 215,683 cases of different brain disorders and 657,164 controls (Table 843	
1), and includes at least one representative of most ICD-10 blocks covering mental and 844	
behavioral disorders and diseases of the central nervous system. Also included are 1,191,588 845	
samples for 13 “behavioral-cognitive” phenotypes (n=744,486) traditionally viewed as brain-846	
related, and four “additional” phenotypes (n=447,102) selected to represent known, well-847	
delineated etiological processes (immune disorders [Crohn’s disease], vascular disease [coronary 848	
artery disease] and anthropomorphic measures [height and BMI]; Table 2).  849	
GWAS summary statistics for the 42 disorders and phenotypes were centralized and 850	
underwent uniform quality control and processing(25)(83). We used European-only meta-851	
analyses for each disorder to avoid potential bias arising from ancestry differences, generating 852	
new meta-analyses for those datasets where the original sample sets had diverse ancestries. 853	
Clinically relevant subtypes from three disorders (epilepsy, migraine, and ischemic stroke) were 854	
also included; in these cases, the subtype datasets are parts of the top-level dataset (Table 1).  855	
We have developed a heritability estimation method, linkage disequilibrium score 856	
regression (LDSC)(24), which was used to calculate heritability estimates and correlations, as 857	
well as to estimate their statistical significance from block jack-knife-based standard errors. 858	
More formally, we estimate the common variant heritability (h2g) of each disorder, defined as the 859	
proportion of phenotypic variance in the population that could theoretically be explained by an 860	
optimal linear predictor formed using the additive effects of all common (minor allele frequency 861	
> 5%) autosomal SNPs. The genetic correlation for a pair of phenotypes is then defined as the 862	
correlation between their optimal genetic predictors. Heritability for binary disorders and 863	
phenotypes was transformed to the liability scale. We further performed a weighted-least squares 864	
regression analysis to evaluate whether differences relating to study makeup (such as sample 865	
size) were correlated with the magnitude of the correlation estimates. Finally, we performed a 866	
heritability partitioning analysis(83) using stratified LD score regression to examine whether the 867	
observed heritability for the disorders or phenotypes was enriched into any of the tissue-specific 868	
regulatory regions or functional category partitions of the genome, using ten top-level tissue-type 869	
and 53 functional partitions from Finucane et al.(26). Finally, simulated phenotype data was 870	
generated under different scenarios by permuting 120,267 genotyped individuals from the UK 871	
Biobank(25) to evaluate power and aid in interpreting the results(83). 872	
 873	
Heritability estimates and their error sources 874	
We observed a similar range of heritability estimates among the disorders and the 875	
behavioral-cognitive phenotypes (Fig. S1A-B and Table S1, S2), roughly in line with previously 876	
reported estimates from smaller datasets (Table S3). Three ischemic stroke subtypes 877	
(cardioembolic, large-vessel disease, and small-vessel disease) as well as the “agreeableness” 878	
personality measure from NEO Five-Factor Inventory(27) had insufficient evidence of additive 879	
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heritability for robust analysis and thus were excluded from further analysis(25). The only 880	
observed correlation between heritability estimates and factors relating to study makeup (Table 881	
S4; Fig. S1C-F) was a modest correlation between age of onset of the disorder and heritability, 882	
suggesting that early-onset brain disorders tend to be more heritable. Since some of our 883	
interpretation of the results depends on lack of observed correlation, we explored the behavior of 884	
observed correlation versus power (Fig. S2A), standard errors (Fig. S2B) and the individual 885	
results (Fig. S2C and D) to identify where we can be reasonably robust in claiming lack of 886	
correlation.  887	
The common variant heritability estimates for the psychiatric and neurological disorders 888	
were generally somewhat lower than previously reported estimates from common variants (Table 889	
S5). A similar pattern was observed for the behavioral-cognitive traits, when comparing 890	
estimates reported here with those previously reported in smaller sample sizes(28)	 with the 891	
exception of ‘openness’, ‘neuroticism’, and ‘never/ever smoked’, suggesting that some 892	
attenuation in heritability is observed when moving to larger sample sizes. Measures related to 893	
cognitive ability, such as childhood cognitive performance (heritability estimate of 0.19, [SE 894	
0.03]) and years of education (heritability estimate of 0.30 [SE 0.01]), yielded estimates that 895	
were more consistent with previous estimates of the heritability of intelligence(29,	 30), 896	
suggesting that the cognitive measures may be less prone to phenotypic measurement error 897	
and/or have a higher heritability overall than the personality measures.  898	
These heritability estimates should be interpreted somewhat cautiously, as they reflect the 899	
phenotype ascertained in each study, and will be deflated in the presence of diagnostic 900	
heterogeneity, ascertainment errors or unusual contributions of high-impact rare variants.	 To 901	
evaluate potential sources of these differences, we explored three approaches(83): evaluating the 902	
differences in real data, simulation work (Table S5), and quantifying the magnitude of effect for 903	
potentially implied misclassification (Table S6).  904	
In comparison to heritability estimates obtained using twin and family data, the more 905	
diverse selection and survival biases in the underlying data may attenuate the heritability 906	
estimates and correlations, as might increased within-disorder heterogeneity introduced by the 907	
larger meta-analyses. A related explanation for the lower estimates of heritability may be that 908	
increasing sample sizes have led to expanded inclusion criteria, meaning that less severely 909	
affected cases with a lower overall burden of risk factors (both genetic and environmental) might 910	
be included, which in turn would attenuate estimates of heritability. However, the successful 911	
identification of genome-wide significant loci suggests that these larger samples are nevertheless 912	
very useful for genetic studies, and the simulation results suggest that this has at most a limited 913	
effect on estimated genetic correlations (Fig S9). Even so, some of the pairs of phenotypes 914	
included here lack sufficient power for robust estimation of genetic correlations. Moreover, our 915	
analyses only examine the properties of common variant contributions and extending these 916	
analyses to include the effects of rare variants may further inform the extent of genetic overlap. 917	
For example, epilepsy and ASD show substantial overlap in genetic risk from de novo loss of 918	
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functional mutations(31), in contrast to the limited common variant sharing observed in this 919	
study. This may suggest that the rare and common variant contributions to genetic overlap may 920	
behave differently and that incorporating the two variant classes into a single analysis may 921	
provide further insight into brain disorder pathogenesis.		922	
To address the possibility of methodological differences contributing to the differences in 923	
the estimates and although LDSC and REML have previously been shown to yield similar 924	
estimates from the same data(24), we performed our own comparison in Alzheimer’s disease(32) 925	
(selected based on data availability). In Alzheimer’s disease, the previously published heritability 926	
estimate (0.24 [SE 0.03]) is significantly different from the estimate in the current study (0.13 927	
[SE 0.02]). These differences may reflect implicit heterogeneity in a much larger case collection 928	
used in the current study (effective sample size 10,494 vs. 46,669) and the potential reasons 929	
listed above, but they could also be due to methodological variability (most of the previous 930	
estimated listed in Table S3 are estimated with a different methodology). To evaluate this, we 931	
applied the same analytical process used in this paper to the summary statistics of the GERAD 932	
cohort (3,941 cases and 7,848 controls) from the Alzheimer’s disease meta-analysis, where the 933	
previous heritability estimate was calculated. There, we obtained a heritability estimate of 0.25 934	
[SE 0.04], which agrees closely with the published estimate of 0.24 [SE 0.03], suggesting that 935	
the different estimates may reflect differences between datasets rather than methodological 936	
variability.	937	
 938	
Correlations among brain disorders 939	
We observed widespread sharing across psychiatric disorders (Fig. 1 and S3) by 940	
expanding the number of brain disorder pairs studied beyond those previously reported(17), but 941	
similar sharing was not observed among neurological disorders. Among the psychiatric 942	
disorders, schizophrenia showed significant genetic correlation with most of the psychiatric 943	
disorders, while MDD was positively (though not necessarily significantly) correlated with every 944	
other disorder tested. Further, schizophrenia, bipolar disorder, anxiety disorders, MDD, and 945	
ADHD each showed a high degree of correlation to the four others (average genetic correlation 946	
[rg]=0.40; Table S7A). Anorexia nervosa, obsessive-compulsive disorder (OCD), and 947	
schizophrenia also demonstrated significant sharing amongst themselves (Fig. 1). However, the 948	
common variant risk of both ASD and Tourette Syndrome (TS) appear to be distinct from other 949	
psychiatric disorders, although with significant correlation between TS, OCD, and MDD, as well 950	
as between ASD and schizophrenia. Similarly, post-traumatic stress disorder (PTSD) showed no 951	
significant correlation with any of the other psychiatric phenotypes (though some correlation to 952	
ADHD and MDD was observed). The modest power of the ASD, PTSD, and TS meta-analyses, 953	
however, limits the strength of this conclusion (Fig. S2C).  954	
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Neurological disorders showed a more limited extent of genetic correlation than the 955	
psychiatric disorders (Fig. 2 and S4, Table S7A), suggesting greater diagnostic specificity and/or 956	
more distinct etiologies. Parkinson’s disease, Alzheimer’s disease, generalized epilepsy, and 957	
multiple sclerosis showed little to no correlation with other brain disorders. The highest degree 958	
of genetic correlation among the neurological disorders was observed with focal epilepsy 959	
(average rg =0.46, excluding the other epilepsy datasets), though none were significant, reflecting 960	
the relatively modest power of the current focal epilepsy meta-analysis (Fig. S2C). However, the 961	
modest heritability and the broad pattern of sharing observed for focal epilepsy may be 962	
consistent with heterogeneity and potentially even diagnostic misclassification across a range of 963	
neurological conditions.  964	
In the cross-category correlation analysis, the observed pattern is consistent with limited 965	
sharing across the included neurological and psychiatric disorders (Fig. 3; average rg=0.03). The 966	
only significant cross-category correlations were with migraine, suggesting it may share some of 967	
its genetic architecture with psychiatric disorders; migraine-ADHD (rg=0.26, p=8.81 x 10-8), 968	
migraine-TS (rg=0.19, p=1.80 x 10-5), and migraine-MDD (rg=0.32, p=1.42 x 10-22 for all 969	
migraine, rg=0.23, p=5.23 x 10-5 for migraine without aura, rg=0.28, p=1.00 x 10-4 for migraine 970	
with aura). 971	
We observed several significant genetic correlations between the behavioral-cognitive or 972	
additional phenotypes and brain disorders (Fig. 4 and Table S7B). Results for cognitive traits 973	
were dichotomous among psychiatric phenotypes (Fig. S5A), with ADHD, anxiety disorders, 974	
MDD, and TS showing negative correlations to the cognitive measures and anorexia nervosa, 975	
ASD, bipolar disorder and OCD showing positive correlations. Schizophrenia showed more 976	
mixed results, with significantly negative correlation to intelligence but positive correlation to 977	
years of education. Among neurological phenotypes (Fig. S5B), the correlations were either 978	
negative or null, with Alzheimer’s disease, epilepsy, ICH, ischemic stroke, early-onset stroke, 979	
and migraine showing significantly negative correlations. Correlations between college 980	
attainment and years of education with bipolar disorder(24), Alzheimer’s disease, and 981	
schizophrenia have been previously reported(33)).  982	
Among the personality and symptom measures, significant positive correlations were 983	
observed between neuroticism and anorexia nervosa, anxiety disorders, migraine, migraine 984	
without aura, MDD, OCD, schizophrenia, and TS (Fig. S6A and S6B; replicating previously 985	
reported correlations with MDD and schizophrenia(34)); between depressive symptoms and 986	
ADHD, anxiety disorder, bipolar disorder, MDD, and schizophrenia; and between subjective 987	
well-being and anxiety disorder, bipolar disorder, and MDD. For smoking-related measures, the 988	
only significant genetic correlations were between never/ever smoked and MDD (rg=0.33, 989	
p=3.10 x 10-11) as well as ADHD (rg=0.37, p=3.15 x 10-6).  990	
Among the additional phenotypes, the two examples of disorders with well-defined 991	
etiologies had different results. Crohn’s disease, representing immunological pathophysiology, 992	
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showed no correlation with any of the study phenotypes, while the phenotype representing 993	
vascular pathophysiology (coronary artery disease) showed significant correlation to MDD 994	
(rg=0.19, p=8.71 x 10-5) as well as the two stroke-related phenotypes (rg=0.69, p=2.47 x 10-6 to 995	
ischemic stroke and rg=0.86, p=2.26 x 10-5 to early-onset stroke), suggesting shared genetic 996	
effects across these phenotypes. Significant correlations were also observed for BMI, which was 997	
positively correlated with ADHD and MDD, and negatively correlated with anorexia nervosa (as 998	
previously reported with a different dataset(24)) and schizophrenia. 999	
Our enrichment analysis (Fig. S7, Tables S8-12) demonstrated significant heritability 1000	
enrichments between central nervous system (CNS) and generalized epilepsy, MDD, TS, college 1001	
attainment, intelligence, neuroticism, never/ever smoked); depressive symptoms and 1002	
adrenal/pancreatic cells and tissues, as well as between hematopoetic cells (category which 1003	
includes immune system cells) and multiple sclerosis (Figs. S7A and S7B, Tables S8 and S9). 1004	
We replicate the reported (CNS) enrichment for schizophrenia, bipolar disorder, and years of 1005	
education (Tables S8, S9), and observe the reported enrichments for BMI (CNS), years of 1006	
education (CNS), height (connective tissues and bone, cardiovascular system and other), and 1007	
Crohn’s disease (hematopoietic cells) from the same datasets (Fig. S7C, D)(26). We further note 1008	
that the psychiatric disorders with large numbers of identified GWAS loci (bipolar disorder, 1009	
MDD, and schizophrenia) and migraine, which was the only cross-correlated neurological 1010	
disorder, show enrichment to conserved regions (Tables S10 and S12), while the other 1011	
neurological disorders with similar numbers of loci (MS, Alzheimer’s, and Parkinson’s diseases) 1012	
do not (Fig. S7A, B). Enrichment to conserved regions was also observed to neuroticism, 1013	
intelligence and college attainment and to H3K9ac peaks for BMI (Tables S11 and S12). 1014	
 1015	
Discussion 1016	
By integrating and analyzing the genome-wide association summary statistic data from 1017	
consortia of 25 brain disorders, we find that psychiatric disorders broadly share a considerable 1018	
portion of their common variant genetic risk,	 especially across schizophrenia, MDD, bipolar 1019	
disorder, anxiety disorder, and ADHD, while neurological disorders are more genetically 1020	
distinct. Across categories, psychiatric and neurologic disorders share relatively little common 1021	
genetic risk, suggesting that multiple different and largely independently regulated etiological 1022	
pathways may give rise to similar clinical manifestations (e.g., psychosis, which manifests in 1023	
both schizophrenia(35) and Alzheimer’s disease(36)). Except for migraine, which appears to 1024	
share some genetic architecture with psychiatric disorders, the existing clinical delineation 1025	
between neurology and psychiatry is corroborated at the level of common variant risk for the 1026	
studied disorders.  1027	
We performed some exploratory analyses based on the observed results to address 1028	
concerns about diagnostic overlap and misclassification, which are particularly relevant to 1029	
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psychiatric disorders due to their spectral nature. Given that the broad and continuous nature of 1030	
psychiatric disorder spectra has long been clinically recognized(37-39) and that patients can, in 1031	
small numbers, progress from one diagnosis to another(40), we evaluated to what extent this kind 1032	
of diagnostic overlap could explain the observed correlations. Genetic correlation could arise if, 1033	
for example, patients progress through multiple diagnoses over their lifetime, or if some specific 1034	
diagnostic boundaries between phenotype pairs are particularly porous to misclassification 1035	
(Table S5). While it would a priori appear unlikely to observe large-scale misclassification of 1036	
migraine as schizophrenia, for example, there may be more substantial misclassification between 1037	
particular psychiatric disorders, consistent with the clinical controversies in classification. 1038	
Previous work(41) suggests that substantial misclassification (on the order of 15-30%, depending 1039	
on whether it is uni- or bi-directional) is required to introduce false levels of genetic correlation. 1040	
We found that the observed levels of correlation are unlikely to appear in the absence of 1041	
underlying genetic correlation (Table S6), as it is apparent that a very high degree of 1042	
misclassification (up to 79%) would be required to produce the observed correlations in the 1043	
absence of any true genetic correlation, and that reasonably expected misclassification would 1044	
have limited impact on the observed rg (Fig. S8). Therefore, these results suggest true sharing of 1045	
a substantial fraction of the common variant genetic architecture among psychiatric disorders as 1046	
well as between behavioral-cognitive measures and brain disorders. We also performed large-1047	
scale simulations to explore the effect of sample size, polygenicity and degree of correlation on 1048	
power to detect significant correlations. First, we established that the observed heritability of the 1049	
simulated misclassified traits in the UK Biobank data behaves as would be theoretically expected 1050	
(Fig. S9A), and that the effects on observed correlation (Fig. S9B and S9C) are in line with the 1051	
estimates from family data(41). Reasonably low levels of misclassification or changes to the 1052	
exact level of heritability appear unlikely to induce significant correlations, as observed in the 1053	
power analysis (Fig. S10), though a lower observed heritability caused by substantial 1054	
misclassification (Fig. S9A) will decrease the power to estimate true genetic overlap. 1055	
The high degree of genetic correlation among the psychiatric disorders adds further 1056	
evidence that current clinical diagnostics do not reflect specific genetic etiology for these 1057	
disorders, and that genetic risk factors for psychiatric disorders do not respect clinical diagnostic 1058	
boundaries. Rather, this suggests a more interconnected genetic etiology, in contrast to 1059	
neurological disorders, and underscores the need to refine psychiatric diagnostics. This study 1060	
may provide important ‘scaffolding’ to support a framework for investigating mental disorders, 1061	
incorporating many levels of information to understand basic dimensions of brain function.  1062	
The observed positive genetic correlations are consistent with a few hypothetical 1063	
scenarios. For example, it may reflect the existence of some portion of common genetic risk 1064	
factors conferring risks for multiple psychiatric disorders and where other distinct additional 1065	
factors, both genetic and non-genetic, contribute to the eventual clinical presentation. The 1066	
presence of significant genetic correlation may also reflect the phenotypic overlap between any 1067	
two disorders; for example, the sharing between schizophrenia and ADHD might reflect 1068	
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underlying difficulties in executive functioning, which are well-established in both disorders(42), 1069	
and that the shared risk arises from a partial capture of its shared genetic component. Similarly, 1070	
we might speculate that a shared mechanism underlying cognitive biases may extend from 1071	
overvalued ideas to delusions (ranging from anorexia nervosa and OCD to schizophrenia), and 1072	
that this heritable intermediate trait confers pleiotropic risk to multiple outcomes. This kind of 1073	
latent variable could give rise to the observed genetic correlation between disorders due to the 1074	
shared portion of variation affecting that variable. While a combination of these is likely, more 1075	
genome-wide significant loci are needed to evaluate these overlaps at the locus level. 1076	
Conversely, the low correlations observed across neurological disorders suggest that the 1077	
current classification reflects relatively specific genetic etiologies, although the limited sample 1078	
size for some of these disorders and lack of inclusion of disorders conceived as “circuit-based” in 1079	
the literature, such as restless legs syndrome, sleep disorders and possibly essential tremor, 1080	
constrains the full generalizability of this conclusion. Degenerative disorders (such as 1081	
Alzheimer’s and Parkinson’s diseases) would not be expected a priori to share their polygenic 1082	
risk profiles with a neuro-immunological disorder (like multiple sclerosis) or neurovascular 1083	
disorder (like ischemic stroke). Similarly, we see limited evidence for the reported co-morbidity 1084	
between migraine with aura and ischemic stroke(43) (rg=0.29, p=0.099); however, the standard 1085	
errors of this comparison are too high to draw strong conclusions. At the disorder subtype level, 1086	
migraine with and without aura (rg=0.48, p=1.79 x 10-5) shows substantial genetic correlation, 1087	
while focal and generalized epilepsy (rg=0.16, p=0.388) show much less.  1088	
The few significant correlations across neurology and psychiatry, namely between 1089	
migraine and ADHD, MDD, and TS, suggest modest shared etiological overlap across the 1090	
neurology/psychiatry distinction. The co-morbidity of migraine with MDD, TS and ADHD has 1091	
been previously reported in epidemiological studies(44-47), while in contrast, the previously 1092	
reported co-morbidity between migraine and bipolar disorder seen in epidemiological studies 1093	
(48) was not reflected in our estimate of genetic correlation (rg=-0.03, p=0.406). 1094	
Several phenotypes show only very low-level correlations with any of the other disorders 1095	
and phenotypes studied here, despite large sample size and robust evidence for heritability, 1096	
suggesting their common variant genetic risk may largely be unique. Alzheimer’s disease, 1097	
Parkinson’s disease, and multiple sclerosis show extremely limited sharing with the other 1098	
phenotypes and with each other. Neuroinflammation has been implicated in the pathophysiology 1099	
of each of these conditions(49-51), as it has for migraine(52) and many psychiatric conditions, 1100	
including schizophrenia(53), but no considerable shared heritability was observed with either of 1101	
those conditions nor with Crohn’s disease, nor did we observe enrichment for immune-related 1102	
tissues in the functional partitioning (Fig. S7) as for Crohn’s disease. While this does not 1103	
preclude the sharing of individual neuroinflammatory mechanisms in these disorders, the large-1104	
scale lack of shared common variant genetic influences supports the distinctiveness of disorder 1105	
etiology. Further, we only observed significant enrichment of heritability for immunological 1106	
cells and tissues in multiple sclerosis, showing that inflammation-specific regulatory marks in 1107	
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the genome do not show overall enrichment for common variant risk for either Alzheimer’s or 1108	
Parkinson’s diseases (though this does not preclude the effects of specific, non-polygenic 1109	
neuroinflammatory mechanisms(54)). Among psychiatric disorders, ASD and TS showed a 1110	
similar absence of correlation with other disorders, although this could reflect small sample 1111	
sizes. 1112	
Analysis of the Big Five personality measures suggest that the current sample sizes may 1113	
be large enough for correlation testing; neuroticism, which has by far the largest sample size, 1114	
shows several significant correlations. Most significant of these was to MDD (rg=0.737, p=5.04 1115	
x 10-96), providing evidence for the link between these phenotypes, as reported for polygenic risk 1116	
scores(55) and twin studies(56, 57); as well as other psychiatric disorders (Fig. 4, Table S7B). 1117	
The correlation between MDD and anxiety disorders, with a similar pattern of correlation and the 1118	
dimensional measures of depressive symptoms, subjective well-being, and neuroticism suggests 1119	
that they all tag a similar underlying etiology. The significant correlation between coronary 1120	
artery disease and MDD supports the link between MDD and CAD(58), while the observed 1121	
correlation between ADHD and smoking initiation (rg=0.374, p=3.15 x 10-6) is consistent with 1122	
the epidemiological evidence of overlap(59) and findings from twin studies(60). 1123	
For the neurological disorders, five (Alzheimer’s disease, intracerebral hemorrhage, 1124	
ischemic and early-onset stroke, and migraine) showed significant negative genetic correlation to 1125	
the cognitive measures, while a two (epilepsy and focal epilepsy) showed moderate negative 1126	
genetic correlation (Fig. S5). For Alzheimer’s disease, poor cognitive performance in early life 1127	
has been linked to increased risk for developing the disorder(61), but to our knowledge no such 1128	
connection has been reported for other phenotypes. Among the psychiatric disorders, ADHD, 1129	
anxiety disorders and MDD show a significant negative correlation to cognitive and education 1130	
attainment measures, while the remaining five of the eight psychiatric disorders (anorexia 1131	
nervosa, ASD, bipolar disorder, OCD, and schizophrenia) showed significant positive genetic 1132	
correlation with one or more cognitive measures. These results suggest the existence of a link 1133	
between cognitive performance in early life and the genetic risk for both psychiatric and 1134	
neurological brain disorders. The basis of the genetic correlations between education, cognition 1135	
and brain disorders may have a variety of root causes including indexing performance 1136	
differences on the basis of behavioral dysregulation (e.g., ADHD relating to attentional problems 1137	
during cognitive tests) or may reflect ascertainment biases in certain disorders conditional on 1138	
impaired cognition (e.g., individuals with lower cognitive reserve being more rapidly identified 1139	
for Alzheimer’s disease), but the results could also suggest a direct link between the underlying 1140	
etiologies.  1141	
BMI shows significant positive genetic correlation to ADHD, consistent with a meta-1142	
analysis linking ADHD to obesity(62), and negative genetic correlation with anorexia nervosa, 1143	
OCD, and schizophrenia. This is consistent with evidence for enrichment of BMI heritability in 1144	
CNS tissues(26) that suggest neuronal involvement(63); this may also provide a partial genetic 1145	
explanation for lower BMI in anorexia nervosa patients even after recovery(64). Given that no 1146	
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strong correlations were observed between BMI and any of the neurological phenotypes, it may 1147	
be that BMI’s brain-specific genetic architecture is more closely related to behavioral 1148	
phenotypes. Ischemic stroke and BMI show surprisingly little genetic correlation in this analysis 1149	
(rg=0.07, p=0.26), suggesting that although BMI is a risk factor for stroke(65), there is little 1150	
evidence for shared common genetic effects. These analyses also suggest that the reported 1151	
reduced rates of cardiovascular disease in individuals with histories of anorexia nervosa(66, 67) 1152	
are more likely due to BMI-related secondary effects. The limited evidence of genetic correlation 1153	
of anorexia nervosa with intracerebral hemorrhage, ischemic stroke, early-onset stroke and 1154	
coronary artery disease suggest that any lower cardiovascular mortality is more likely due to 1155	
direct BMI-related effects rather than genetic risk variants.  1156	
The genetic correlation results presented here indicate that the clinical boundaries for the 1157	
studied psychiatric phenotypes do not reflect distinct underlying pathogenic processes. This 1158	
suggests that genetically informed analyses may provide a basis for restructuring of psychiatric 1159	
nosology, consistent with twin and family-based results. In contrast, neurological disorders show 1160	
greater genetic specificity, and although it is important to emphasize that while some brain 1161	
disorders are under-represented here, our results demonstrate the limited evidence for widespread 1162	
common genetic risk sharing between psychiatric and neurological disorders. However, we 1163	
provide strong evidence that both psychiatric and neurological disorders show robust correlations 1164	
with cognitive and personality measures, suggesting new avenues for follow-up studies. Further 1165	
study is needed to evaluate whether overlapping genetic contributions to psychiatric pathology 1166	
may influence treatment choices. Ultimately, such developments give hope to reducing 1167	
diagnostic heterogeneity and eventually improving the diagnostics and treatment of psychiatric 1168	
disorders.  1169	
Materials and Methods 1170	
We collected GWAS meta-analysis summary statistics for 25 brain disorders and 17 other 1171	
phenotypes from various consortia, and where necessary generated new, non-sex-stratified 1172	
European-cohorts-only versions of the meta-analyses(25). All datasets underwent uniform 1173	
quality control (83). For each trait, using the linkage disequilibrium score (LDSC) 1174	
framework(24), the total additive common SNP heritability present in the summary statistics 1175	
(h2g) was estimated by regressing the association χ2 statistic of a SNP against the total amount of 1176	
common genetic variation tagged by that SNP, for all SNPs. Genetic correlations (rg; i.e., the 1177	
genome-wide average shared genetic risk) for pairs of phenotypes were estimated by regressing 1178	
the product of Z-score for each phenotype and for each SNP, instead of the χ2 statistic. 1179	
Significance was assessed by Bonferroni multiple testing correction via estimating the number of 1180	
independent brain disorder phenotypes via matrix decomposition (83). Functional and 1181	
partitioning analyses for the GWAS datasets were also performed using LDSC. Power analyses 1182	
and simulation work to aid in interpretation of the results were conducted using genotype data 1183	
from the UK Biobank Resource (83). 1184	
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Figure 1. Genetic correlations across psychiatric phenotypes.  1508	
 1509	
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance 1510	
(LDSC), with significant correlations filling each box completely. Asterisks indicate genetic correlations which are 1511	
significantly different from zero after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – 1512	
autism spectrum disorder; MDD – major depressive disorder; OCD – obsessive-compulsive disorder; PTSD – post-1513	
traumatic stress disorder.  1514	
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Figure 2. Genetic correlations across neurological phenotypes.  1515	
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance 1516	
(LDSC), with significant correlations filling each box completely. Asterisks indicate genetic correlations which are 1517	
significantly different from zero after Bonferroni correction. Some phenotypes have substantial overlaps (see Table 1518	
1), e.g. all cases of generalized epilepsy are also cases of epilepsy. Asterisks indicate significant genetic correlation 1519	
after multiple testing correction. ICH – intracerebral hemorrhage. 1520	
  1521	
	37	
	
Figure 3. Genetic correlations across neurological and psychiatric phenotypes.  1522	
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance 1523	
(LDSC), with significant correlations filling each box completely. Asterisks indicate genetic correlations which are 1524	
significantly different from zero after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – 1525	
autism spectrum disorder; ICH – intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-1526	
compulsive disorder; PTSD – post-traumatic stress disorder.  1527	
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Figure 4. Genetic correlations across brain disorders and behavioral-cognitive phenotypes.  1528	
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance 1529	
(LDSC), with significant correlations filling each box completely. Asterisks indicate genetic correlations which are 1530	
significantly different from zero after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – 1531	
autism spectrum disorder; ICH – intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-1532	
compulsive disorder; PTSD – post-traumatic stress disorder; BMI –body-mass index.  1533	
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Table 1. Brain disorder phenotypes used in the Brainstorm project.  1534	
 1535	
Indented phenotypes are part of a larger whole, e.g. the epilepsy study contains the samples from both focal epilepsy 1536	
and generalized epilepsy; sample counts for such overlaps are shown in gray. ADHD – attention deficit 1537	
hyperactivity disorder; OCD – obsessive-compulsive disorder. ‘Anxiety disorders’ refers to a meta-analysis of five 1538	
subtypes (generalized anxiety disorder, panic disorder, social phobia, agoraphobia, and specific phobias). 1539	
References are listed in Table S1 and data availability in Table S13. 1540	
  1541	
Psychiatric	disorders Neurological	disorders
Disorder Source Cases Controls Disorder Source Cases Controls
ADHD PGC-ADD2 12,645 84,435 Alzheimer's	disease IGAP 17,008 37,154
Anorexia	nervosa PGC-ED 3,495 11,105 Epilepsy ILAE 7,779 20,439
Anxiety	disorders ANGST 5,761 11,765 			Focal	epilepsy " 4,601 17,985
Autism	spectrum	disorder PGC-AUT 6,197 7,377 			Generalized	epilepsy " 2,525 16,244
Bipolar	disorder PGC-BIP2 20,352 31,358 Intracerebral	hemorrhage ISGC 1,545 1,481
Major	depressive	disorder PGC-MDD2 16,823 25,632 Ischemic	stroke METASTROKE 10,307 19,326
OCD PGC-OCDTS 2,936 7,279 				Cardioembolic	stroke " 1,859 17,708
PTSD PGC-PTSD 2,424 7,113 				Early-onset	stroke " 3,274 11,012
Schizophrenia PGC-SCZ2 33,640 43,456 				Large-vessel	disease " 1,817 17,708
Tourette	Syndrome PGC-OCDTS 4,220 8,994 				Small-vessel	disease " 1,349 17,708
Migraine IHGC 59,673 316,078
			Migraine	with	aura " 6,332 142,817
			Migraine	without	aura " 8,348 136,758
Multiple	sclerosis IMSGC 5,545 12,153
Parkinson's	disease IPDGC 5,333 12,019
Total	psychiatric 108,493 238,514 Total	neurologic 107,190 418,650
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Table 2. Behavioral-cognitive and additional phenotypes used in the study.  1542	
  1543	
Indented phenotypes are part of a larger whole, e.g. samples in the college attainment analysis are a subset of those 1544	
in the analysis for years of education; sample counts for such overlaps are shown in gray. (d) – dichotomous 1545	
phenotype, (q) – quantitative phenotype. BMI – body-mass index. References and phenotype definitions are listed in 1546	
Table S2, and data availability in Table S13.  1547	
  1548	
Phenotype Source Samples
Behavioral-cognitive	phenotypes
Cognitive
			Years	of	education	(q) SSGAC 293,723
			College	attainment	(d) " 120,917
			Cognitive	performance	(q) " 17,989
			Intelligence	(d) CTG 78,308
Personality	measures
			Subjective	well-being SSGAC 298,420
			Depressive	symptoms " 161,460
			Neuroticism	(q) " 170,911
			Extraversion	(q) GPC 63,030
			Agreeableness	(q) " 17,375
			Conscientiousness	(q) " 17,375
			Openness	(q) " 17,375
Smoking-related
			Never/ever	smoked	(d) TAG 74,035
			Cigarettes	per	day	(q) TAG 38,617
Additional	phenotypes
			BMI	(q) GIANT 339,224
			Height	(q) " 253,288
			Coronary	artery	disease	(d) Cardiogram 86,995
			Crohn's	disease	(d) IIBDGC 20,883
Total 1,124,048
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